BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 24323911)

  • 1. Role of sphingolipids in oestrogen signalling in breast cancer cells: an update.
    Sukocheva O; Wadham C
    J Endocrinol; 2014 Mar; 220(3):R25-35. PubMed ID: 24323911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of sphingolipids in the cytoplasmic signaling of estrogens.
    Sukocheva O; Wadham C; Xia P
    Steroids; 2009 Jul; 74(7):562-7. PubMed ID: 19167412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer oestrogen independence mediated by BCAR1 or BCAR3 genes is transmitted through mechanisms distinct from the oestrogen receptor signalling pathway or the epidermal growth factor receptor signalling pathway.
    Dorssers LC; van Agthoven T; Brinkman A; Veldscholte J; Smid M; Dechering KJ
    Breast Cancer Res; 2005; 7(1):R82-92. PubMed ID: 15642172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First evidence supporting a potential role for the BMP/SMAD pathway in the progression of oestrogen receptor-positive breast cancer.
    Helms MW; Packeisen J; August C; Schittek B; Boecker W; Brandt BH; Buerger H
    J Pathol; 2005 Jul; 206(3):366-76. PubMed ID: 15892165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions between the oestrogen and insulin-like growth factor signalling pathways in the control of breast epithelial cell proliferation.
    Westley BR; Clayton SJ; Daws MR; Molloy CA; May FE
    Biochem Soc Symp; 1998; 63():35-44. PubMed ID: 9513709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sphingolipid metabolites in neural signalling and function.
    Colombaioni L; Garcia-Gil M
    Brain Res Brain Res Rev; 2004 Nov; 46(3):328-55. PubMed ID: 15571774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sphingolipid breakdown products: anti-proliferative and tumor-suppressor lipids.
    Hannun YA; Linardic CM
    Biochim Biophys Acta; 1993 Dec; 1154(3-4):223-36. PubMed ID: 8280742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgens and estrogens stimulate ribosome biogenesis in prostate and breast cancer cells in receptor dependent manner.
    Ray S; Johnston R; Campbell DC; Nugent S; McDade SS; Waugh D; Panov KI
    Gene; 2013 Aug; 526(1):46-53. PubMed ID: 23608168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oestrogen-dependent regulation of miRNA biogenesis: many ways to skin the cat.
    Gupta A; Caffrey E; Callagy G; Gupta S
    Biochem Soc Trans; 2012 Aug; 40(4):752-8. PubMed ID: 22817728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Principles of bioactive lipid signalling: lessons from sphingolipids.
    Hannun YA; Obeid LM
    Nat Rev Mol Cell Biol; 2008 Feb; 9(2):139-50. PubMed ID: 18216770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated ERK1/ERK2/estrogen receptor cross-talk enhances estrogen-mediated signaling during long-term estrogen deprivation.
    Martin LA; Farmer I; Johnston SR; Ali S; Dowsett M
    Endocr Relat Cancer; 2005 Jul; 12 Suppl 1():S75-84. PubMed ID: 16113101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond a structural component: sphingolipids in immunology.
    Prieschl EE; Baumruker T
    Arch Immunol Ther Exp (Warsz); 2000; 48(3):163-71. PubMed ID: 10912620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of sphingosine kinase and sphingolipid signaling.
    Pitson SM
    Trends Biochem Sci; 2011 Feb; 36(2):97-107. PubMed ID: 20870412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between the insulin-like growth factor-1 system and the oestrogen metabolising enzymes in breast cancer tissue and its adjacent non-cancerous tissue.
    Chong YM; Colston K; Jiang WG; Sharma AK; Mokbel K
    Breast Cancer Res Treat; 2006 Oct; 99(3):275-88. PubMed ID: 16752221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sphingolipid-mediated apoptotic signaling pathways].
    Cuvillier O; Andrieu-Abadie N; Ségui B; Malagarie-Cazenave S; Tardy C; Bonhoure E; Levade T
    J Soc Biol; 2003; 197(3):217-21. PubMed ID: 14708343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sphingolipids and the regulation of the immune response.
    Baumruker T; Prieschl EE
    Semin Immunol; 2002 Feb; 14(1):57-63. PubMed ID: 11884231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide and sphingolipids: mechanisms of interaction and role in cellular pathophysiology.
    Perrotta C; De Palma C; Clementi E
    Biol Chem; 2008 Nov; 389(11):1391-7. PubMed ID: 18783333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sphingosine kinases, sphingosine-1-phosphate and sphingolipidomics.
    Maceyka M; Milstien S; Spiegel S
    Prostaglandins Other Lipid Mediat; 2005 Sep; 77(1-4):15-22. PubMed ID: 16099387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane-initiated steroid signaling action of estrogen and breast cancer.
    Song RX
    Semin Reprod Med; 2007 May; 25(3):187-97. PubMed ID: 17447208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor-I and cancer risk.
    Ibrahim YH; Yee D
    Growth Horm IGF Res; 2004 Aug; 14(4):261-9. PubMed ID: 15231294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.